Actively Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Led by Vanda Pharmaceuticals · Updated on 2026-02-27
240
Participants Needed
28
Research Sites
58 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension
CONDITIONS
Official Title
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 65 years
- Sitting systolic blood pressure of 130 mmHg or higher despite more than 8 weeks of treatment with one or more antihypertensive therapies
You will not qualify if you...
- Confirmed severe hypertension with sitting systolic blood pressure 180 mmHg or higher or diastolic blood pressure 120 mmHg or higher
- Unstable cardiac disease
- Renal insufficiency
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 28 locations
1
Vanda Investigative Site
Phoenix, Arizona, United States, 85053
Not Yet Recruiting
2
Vanda Investigative Site
Tempe, Arizona, United States, 85281
Actively Recruiting
3
Vanda Investigative Site
Tucson, Arizona, United States, 85715
Not Yet Recruiting
4
Vanda Investigative Site
Chula Vista, California, United States, 91910
Actively Recruiting
5
Vanda Investigative Site
Dublin, California, United States, 94568
Actively Recruiting
6
Vanda Investigative Site
Valencia, California, United States, 91355
Not Yet Recruiting
7
Vanda Investigative Site
Walnut Creek, California, United States, 94596
Actively Recruiting
8
Vanda Investigative Site
Doral, Florida, United States, 33172
Not Yet Recruiting
9
Vanda Investigative Site
Fort Myers, Florida, United States, 33912
Actively Recruiting
10
Vanda Investigative Site
Columbus, Georgia, United States, 31904
Actively Recruiting
11
Vanda Investigative Site
Oak Brook, Illinois, United States, 60523
Actively Recruiting
12
Vanda Investigative Site
Tinley Park, Illinois, United States, 60477
Actively Recruiting
13
Vanda Investigative Site
El Dorado, Kansas, United States, 67042
Actively Recruiting
14
Vanda Investigative Site
Wichita, Kansas, United States, 67226
Actively Recruiting
15
Vanda Investigative Site
Lexington, Kentucky, United States, 40509
Actively Recruiting
16
Vanda Investigative Site
Hazelwood, Missouri, United States, 63042
Actively Recruiting
17
Vanda Investigative Site
Las Vegas, Nevada, United States, 89119
Not Yet Recruiting
18
Vanda Investigative Site
Mount Kisco, New York, United States, 10549
Not Yet Recruiting
19
Vanda Investigative Site
Rochester, New York, United States, 14609
Not Yet Recruiting
20
Vanda Investigative Site
Kinston, North Carolina, United States, 28501
Actively Recruiting
21
Vanda Investigative Site
Cincinnati, Ohio, United States, 45212
Actively Recruiting
22
Vanda Investigative Site
Norman, Oklahoma, United States, 73069
Actively Recruiting
23
Vanda Investigative Site
Oklahoma City, Oklahoma, United States, 73112
Not Yet Recruiting
24
Vanda Investigative Site
Charleston, South Carolina, United States, 29414
Actively Recruiting
25
Vanda Investigative Site
Carrollton, Texas, United States, 75006
Not Yet Recruiting
26
Vanda Investigative Site
Salt Lake City, Utah, United States, 84124
Not Yet Recruiting
27
Vanda Investigative Site
Burke, Virginia, United States, 22015
Actively Recruiting
28
Vanda Investigative Site
Norfolk, Virginia, United States, 23502
Actively Recruiting
Research Team
V
Vanda Pharmaceuticals, Inc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here